Fidia Balance Sheet Health
Financial Health criteria checks 3/6
Fidia has a total shareholder equity of €4.6M and total debt of €1.0M, which brings its debt-to-equity ratio to 22.3%. Its total assets and total liabilities are €30.7M and €26.1M respectively.
Key information
22.3%
Debt to equity ratio
€1.02m
Debt
Interest coverage ratio | n/a |
Cash | €2.13m |
Equity | €4.58m |
Total liabilities | €26.10m |
Total assets | €30.69m |
Recent financial health updates
Recent updates
Investors Give Fidia S.p.A. (BIT:FDA) Shares A 34% Hiding
Oct 18It's Down 40% But Fidia S.p.A. (BIT:FDA) Could Be Riskier Than It Looks
Aug 29Further Upside For Fidia S.p.A. (BIT:FDA) Shares Could Introduce Price Risks After 28% Bounce
Jun 20Estimating The Fair Value Of Fidia S.p.A. (BIT:FDA)
May 28Risks Still Elevated At These Prices As Fidia S.p.A. (BIT:FDA) Shares Dive 31%
Feb 13Is Fidia (BIT:FDA) A Risky Investment?
Dec 23Fidia S.p.A.'s (BIT:FDA) Business Is Trailing The Industry But Its Shares Aren't
Oct 04Financial Position Analysis
Short Term Liabilities: FDA's short term assets (€20.6M) do not cover its short term liabilities (€20.7M).
Long Term Liabilities: FDA's short term assets (€20.6M) exceed its long term liabilities (€5.4M).
Debt to Equity History and Analysis
Debt Level: FDA has more cash than its total debt.
Reducing Debt: FDA's debt to equity ratio has reduced from 153.2% to 22.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: FDA has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: FDA has less than a year of cash runway if free cash flow continues to reduce at historical rates of 18.1% each year